Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC

Huaqiang Zhou1, Jiayi Shen2, Jiaqing Liu3

  • 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.

Abstract

No abstract available in PubMed .

Related Concept Videos